SEAL @671 (54.5%) on 17-dec-2012 [ 1 ] using hospira
CPL @1111 (55.9%) on 25-jun-2018 [ "chief scientific officer at _" "_ filed an ANDA" "honoraria from _" "investor relations section of _" "Analysts seem relatively indifferent about _" "unofficial affiliation with _" "heparin manufactured by _" "_ 's heparin" "drug makers like _" "brand name owned by _" "drug is manufactured by _" "_ 's broad portfolio" "education grant from _" "_ stopped making the drug" "drug made by _" "speaker fees from _" "educational grant from _" "market space include _" "_ 's supplier diversity program" "relations section of _" "_ manufactures medical devices" "Neutral rating on _" "Key players covered include _" "DEA has investigated _" "unrestricted educational grant from _" "drug companies like _" "drug company called _" "players covered include _" ] using hospira